SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-037013
Filing Date
2023-06-14
Accepted
2023-06-14 16:20:20
Documents
2
Period of Report
2023-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1610
2 POA DOCUMENT poa.txt EX-24 4761
  Complete submission text file 0001209191-23-037013.txt   7716
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OCERA THERAPEUTICS, INC. 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Patni Rajiv (Reporting) CIK: 0001616200 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37785 | Film No.: 231014383